
 
 
 
 
 
 
 
 
 The embodiments of the invention in which an exclusive property of privilege is claimed are defined as follows:  
   
 1. A monoclonal antibody specific for soluble and membrane associated human estrogen-stimulated leucine aminopeptidase (es-LAPase), produced by hybridoma cell line 7B6, deposited with the International Depository Authority of Canada under Accession number IDAC 230300-1. 
 
     
 2. A hybridoma cell line which produces a monoclonal antibody specific for soluble and membrane associated human estrogen-stimulated leucine aminopeptidase (es-LAPase), as deposited with the International Depository Authority of Canada under Accession number IDAC 230300-1. 
 
   
 
 
 
 
 
 
 
 
